值得重视的体重:肥胖与意义未明单克隆丙种球蛋白病向多发性骨髓瘤的转变
本综述总结了肥胖在多发性骨髓瘤(MM)和意义未明单克隆丙种球蛋白病(MGUS)中的流行病学证据,讨论了驱动这些疾病过程的生物学机制,并详述了可能降低MGUS向MM进展风险的肥胖靶向药物和生活方式干预。
要点
- 肥胖是MM和MGUS的危险因素,并可能促进MGUS向MM转变。
- 综述总结了肥胖在MM和MGUS中作用的流行病学证据及生物学机制。
- 详述了可能降低MGUS向MM进展风险的肥胖靶向药物和生活方式干预。
核心结论
- 肥胖不仅是MM和MGUS的危险因素,还可能促进MGUS向MM的转变。
研究设计与样本
- 综述,总结肥胖在MM和MGUS中作用的流行病学证据、生物学机制及肥胖靶向干预。
主要发现
- 超重/肥胖影响全球超过40%的成年人,增加多种慢性疾病风险。
- 近期研究显示肥胖是MM和MGUS的危险因素。
- 肥胖可能促进MGUS向MM的转变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The overweight/obesity epidemic is a serious public health concern that affects >40% of adults globally and increases the risk of numerous chronic diseases, such as type 2 diabetes, heart disease, and various cancers. Multiple myeloma (MM) is a lymphohematopoietic cancer caused by the uncontrolled clonal expansion of plasma cells. Recent studies have shown that obesity is a risk factor not only for MM but also monoclonal gammopathy of undetermined significance (MGUS), a precursor disease state of MM. Furthermore, obesity may promote the transition from MGUS to MM. Thus, in this review, we summarize the epidemiological evidence regarding the role of obesity in MM and MGUS, discuss the biologic mechanisms that drive these disease processes, and detail the obesity-targeted pharmacologic and lifestyle interventions that may reduce the risk of progression from MGUS to MM.
引用
- Choa R, Panaroni C, Bhatia R, et al. It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma. Blood Adv. 2023. PMID: 37493975. doi:10.1182/bloodadvances.2023010822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。